ADJUVANT 5 FU-IRRADIATION-5 FU FOLLOWING MASTECTOMY IN HIGH-RISK PATIENTS

被引:0
|
作者
RAMIREZ, G
机构
[1] UNIV WISCONSIN,DIV CLIN ONCOL,MADISON,WI 53706
[2] UNIV WISCONSIN,DIV RADIOTHERAPY,MADISON,WI 53706
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:49 / 49
页数:1
相关论文
共 50 条
  • [1] 5-FU AS AN ADJUVANT TO MASTECTOMY IN HIGH-RISK PATIENTS
    ANSFIELD, FJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 177 - 177
  • [2] SIGNIFICANCE OF RELAPSE FOLLOWING ADJUVANT THERAPY WITH CMF OR 5-FU IN HIGH-RISK BREAST-CANCER
    CHLEBOWSKI, RT
    WEINER, JM
    LUCE, J
    HESTORFF, R
    LANG, JE
    REYNOLDS, R
    GODFREY, T
    RYDEN, VMJ
    BATEMAN, JR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 146 - 146
  • [3] ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL (5-FU) OR 5-FU PLUS METHYL-CCNU FOLLOWING SURGERY IN COLONIC CANCER
    DEXEUS, FA
    THIRLWELL, MP
    MACFARLANE, JK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 367 - 367
  • [4] Methotrexate (MTX) and 5-fluorouracil (5-FU) in advanced colorectal cancer patients previously treated with adjuvant 5-FU
    Pronzato, P
    Vaira, F
    Viganni, A
    Losardo, P
    Bertelli, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 760 - 760
  • [5] Efficacy of adjuvant chemotherapy with 5-FU/leucovorin and 5-FU/levamisole colon cancer
    Porschen, R
    Bermann, A
    Löffler, T
    Haack, G
    Rettig, K
    Anger, Y
    Strohmeyer, G
    GASTROENTEROLOGY, 1998, 114 (04) : A664 - A664
  • [6] Adjuvant 5-FU and heparin prevent PVR
    Allinson, RW
    OPHTHALMOLOGY, 2002, 109 (05) : 829 - 830
  • [7] Adjuvant chemoradiotherapy (CRT) for high-risk gastric cancer (GC) patients: single-center experience using infusional 5-fluorouracil (5FU) and radiotherapy (RT)
    K. Papadimitriou
    V. Vassiliou
    P. Kountourakis
    P. Polyviou
    D. Andreopoulos
    D. Papamichael
    Medical Oncology, 2012, 29 : 2716 - 2717
  • [8] Adjuvant chemoradiotherapy (CRT) for high-risk gastric cancer (GC) patients: single-center experience using infusional 5-fluorouracil (5FU) and radiotherapy (RT)
    Papadimitriou, K.
    Vassiliou, V.
    Kountourakis, P.
    Polyviou, P.
    Andreopoulos, D.
    Papamichael, D.
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2716 - 2717
  • [9] ADJUVANT 5-FU AND MECCNU IMPROVES SURVIVAL FOLLOWING CURATIVE GASTRECTOMY FOR ADENOCARCINOMA
    CLARK, JL
    BARCEWICZ, P
    NAVA, HR
    GOODWIN, PS
    DOUGLASS, HO
    AMERICAN SURGEON, 1990, 56 (07) : 423 - 427
  • [10] INCIDENCE OF HYPERTRIGLYCERIDEMIA IN PATIENTS RECEIVING 5FU AND LEVAMISOLE ADJUVANT CHEMOTHERAPY
    ROSS, AB
    CARRON, DA
    PARKER, HW
    MATTHAEUS, WG
    FRICK, JC
    OESTERLING, KF
    HOGAN, WJ
    GASTROENTEROLOGY, 1994, 106 (04) : A434 - A434